Although oxLDL/β2-GPI levels significantly decreased with anti-TNF therapy, BNP, suPAR, and anti-Hsp60 levels remained unchanged, reinforcing the complexity of vascular response in RA. This evidence concerns the gene NPPB and rheumatoid arthritis.